September 15, 2025

Assessing the risk of heart failure in patients with acute kidney injury

September 15, 2025 / Clinical Practice / InnovateMed Author / acute kidney injury

by Avi Patel, Yale University edited by Lisa Lock, reviewed by Andrew Zinin ROC curves for the prediction of heart failure events or death at 3 years using different models. Credit: BMC Nephrology (2025). DOI: 10.1186/s12882-025-04169-1 When Sherry Mansour, MD, assistant professor of medicine (nephrology), first began her training at Yale, she was struck by the high rates of heart […]

Assessing the risk of heart failure in patients with acute kidney injury Read More »

Medical lenses for early eye disease detection

Sponsored Content by Avantier Inc.Reviewed by Andrea SalazarSep 11 2025 Medical detection lenses developed for identifying eye diseases are classified into two categories based on optical working distance: long-distance detection lenses and zero-distance detection lenses. Long-distance detection lens (Approximately 15 MM from the eye) Advantages: The non-contact design ensures safety, allowing for painless lesion detection that minimizes discomfort

Medical lenses for early eye disease detection Read More »

Colostrum for Adults: Boosting Immunity Gut Health and Recovery

September 15, 2025 / Patient education / InnovateMed Author / colostrum

By Vijay Kumar MalesuReviewed by Susha Cheriyedath, M.Sc. -Introduction -Composition of Colostrum -Immunity-Boosting Effects -Gut Health and Barrier Function -Tissue Repair and Recovery -Emerging Applications -Safety, Limitations, and Challenges -Conclusions -Related video -References -Further reading Colostrum contains bioactive compounds that support adult immunity, gut integrity, and tissue repair. Early clinical trials show promising results, but larger studies

Colostrum for Adults: Boosting Immunity Gut Health and Recovery Read More »

AI can predict which patients need treatment to preserve their eyesight

September 15, 2025 / Research update / InnovateMed Author / eyesight

European Society of Cataract and Refractive Surgeons Sep 15, 2025 Researchers have successfully used artificial intelligence (AI) to predict which patients need treatment to stabilize their corneas and preserve their eyesight, in a study presented today (Sunday) at the 43rd Congress of the European Society of Cataract and Refractive Surgeons (ESCRS). The research focused on people

AI can predict which patients need treatment to preserve their eyesight Read More »

Stress in the strands: Hair offers clues to children’s mental health

September 15, 2025 / Mental Health, Research update / InnovateMed Author / stress

University of Waterloo study shows long-term stress levels may signal mental health risks in children with chronic physical illnesses and guide early intervention Peer-Reviewed Publication University of Waterloo Long-term stress levels, measured through hair samples, may provide important clues about mental health risks in children with chronic physical illnesses (CPI), according to new research from

Stress in the strands: Hair offers clues to children’s mental health Read More »

Mayo Clinic study reveals hidden causes of heart attacks in younger adults, especially women

September 15, 2025 / Research update / InnovateMed Author / heart attack

Peer-Reviewed Publication Mayo Clinic ROCHESTER, Minn. — A new Mayo Clinic study finds that many heart attacks in people under 65 — especially women — are caused by factors other than clogged arteries, challenging long-standing assumptions about how heart attacks occur in younger populations. Study findings published in the Journal of the American College of Cardiology examined over 15 years of data

Mayo Clinic study reveals hidden causes of heart attacks in younger adults, especially women Read More »

New pill lowers stubborn BP in kidney patients

September 15, 2025 / Research update / InnovateMed Author / BP

by Deanna Neff edited by Andrew Zinin A novel pill that blocks the hormone aldosterone shows promise for lowering blood pressure and potentially delaying the progression of kidney disease in people with both conditions. The preliminary findings were presented Saturday at an American Heart Association (AHA) meeting in Baltimore and simultaneously published in the Journal of the

New pill lowers stubborn BP in kidney patients Read More »

Dry eyes affect over half the general population, yet only a fifth receive diagnosis and treatment

September 15, 2025 / Clinical Practice / InnovateMed Author / dry eyes

by European Society of Cataract and Refractive Surgeons edited by Stephanie Baum, reviewed by Robert Egan Credit: CC0 Public Domain Dry eyes can cause significant discomfort, and the symptoms become more common as we age. However, until now, it was unclear what proportion of the population suffered from the condition, with estimates ranging from 5–50%. In

Dry eyes affect over half the general population, yet only a fifth receive diagnosis and treatment Read More »

Researchers sound warning about women with type 2 diabetes taking oral hormone replacement therapy

September 15, 2025 / Research update / InnovateMed Author / type 2 diabetes

by European Association for the Study of Diabetes edited by Sadie Harley, reviewed by Robert Egan Credit: Unsplash/CC0 Public Domain In women with type 2 diabetes (T2D), use of hormone replacement therapy (HRT) skin patches is not associated with a higher risk of blood clots or stroke. However, an increased cardiovascular risk was found for oral HRT,

Researchers sound warning about women with type 2 diabetes taking oral hormone replacement therapy Read More »

Higher doses of semaglutide can safely enhance weight loss for adults living with obesity, clinical trials confirm

September 15, 2025 / Research update / InnovateMed Author / Weight loss

by Lancet edited by Stephanie Baum, reviewed by Robert Egan Credit: Pixabay from Pexels A higher weekly dose of semaglutide (7.2 mg) can significantly improve weight loss and related health outcomes in adults living with obesity, including those with type 2 diabetes (T2D), according to the results of two large-scale, international phase 3 clinical trials. The findings, published

Higher doses of semaglutide can safely enhance weight loss for adults living with obesity, clinical trials confirm Read More »